LU87034A1 - Association medicamenteuse a base d'un inhibiteur calcique - Google Patents

Association medicamenteuse a base d'un inhibiteur calcique Download PDF

Info

Publication number
LU87034A1
LU87034A1 LU87034A LU87034A LU87034A1 LU 87034 A1 LU87034 A1 LU 87034A1 LU 87034 A LU87034 A LU 87034A LU 87034 A LU87034 A LU 87034A LU 87034 A1 LU87034 A1 LU 87034A1
Authority
LU
Luxembourg
Prior art keywords
alkyl
group
alkoxy
cycloalkyl
hydroxy
Prior art date
Application number
LU87034A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868626217A external-priority patent/GB8626217D0/en
Priority claimed from GB878713349A external-priority patent/GB8713349D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU87034A1 publication Critical patent/LU87034A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU87034A 1986-11-03 1987-10-30 Association medicamenteuse a base d'un inhibiteur calcique LU87034A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB868626217A GB8626217D0 (en) 1986-11-03 1986-11-03 Pharmaceutical compositions
GB8626217 1986-11-03
GB878713349A GB8713349D0 (en) 1987-06-08 1987-06-08 Pharmaceutical compositions
GB8713349 1987-06-08

Publications (1)

Publication Number Publication Date
LU87034A1 true LU87034A1 (fr) 1988-05-03

Family

ID=26291485

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87034A LU87034A1 (fr) 1986-11-03 1987-10-30 Association medicamenteuse a base d'un inhibiteur calcique

Country Status (25)

Country Link
KR (1) KR960005145B1 (fi)
AT (1) AT397343B (fi)
AU (1) AU615883B2 (fi)
BE (1) BE1002063A4 (fi)
CA (1) CA1314222C (fi)
CH (1) CH677189A5 (fi)
DE (1) DE3736505A1 (fi)
DK (1) DK574087A (fi)
ES (1) ES2010524A6 (fi)
FI (1) FI874823A (fi)
FR (1) FR2605885B1 (fi)
GR (1) GR871680B (fi)
HK (1) HK138893A (fi)
HU (1) HU199681B (fi)
IE (1) IE60496B1 (fi)
IL (1) IL84343A (fi)
IT (1) IT1212037B (fi)
LU (1) LU87034A1 (fi)
MY (1) MY102124A (fi)
NL (1) NL8702502A (fi)
NO (1) NO874539L (fi)
NZ (1) NZ222401A (fi)
PH (1) PH23249A (fi)
PT (1) PT86062B (fi)
SE (1) SE8704272L (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
FR2733911B1 (fr) * 1995-05-09 1998-05-29 Takeda Chemical Industries Ltd Composition pharmaceutique pour maladies renales ou cardio-vasculaires

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) * 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
US4520021A (en) * 1982-07-02 1985-05-28 Merck & Co., Inc. Substituted caprolactam derivatives as antihypertensives
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
GB2198641B (en) * 1986-11-03 1990-09-19 Sandoz Ltd Pharmaceutical composition for use against hypertension and congestive heart failure
IL88502A (en) * 1987-12-14 1993-04-04 Squibb & Sons Inc Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor

Also Published As

Publication number Publication date
HUT47847A (en) 1989-04-28
GR871680B (en) 1988-05-02
FR2605885A1 (fr) 1988-05-06
NO874539L (no) 1988-05-04
FI874823A (fi) 1988-05-04
HU199681B (en) 1990-03-28
AU8057687A (en) 1988-05-05
PT86062B (pt) 1990-11-07
IL84343A0 (en) 1990-02-09
ES2010524A6 (es) 1989-11-16
IL84343A (en) 1993-07-08
KR960005145B1 (ko) 1996-04-22
CA1314222C (en) 1993-03-09
CH677189A5 (fi) 1991-04-30
DK574087A (da) 1988-05-04
NZ222401A (en) 1991-04-26
ATA286987A (de) 1993-08-15
IE872951L (en) 1988-05-03
PH23249A (en) 1989-06-16
SE8704272D0 (sv) 1987-11-02
MY102124A (en) 1992-03-31
PT86062A (en) 1987-12-01
AU615883B2 (en) 1991-10-17
IE60496B1 (en) 1994-07-27
IT1212037B (it) 1989-11-08
SE8704272L (sv) 1988-05-04
FR2605885B1 (fr) 1993-09-10
NO874539D0 (no) 1987-11-02
DK574087D0 (da) 1987-11-02
FI874823A0 (fi) 1987-11-02
BE1002063A4 (fr) 1990-06-12
IT8748553A0 (it) 1987-10-30
HK138893A (en) 1993-12-24
DE3736505A1 (de) 1988-05-05
NL8702502A (nl) 1988-06-01
AT397343B (de) 1994-03-25
KR880006197A (ko) 1988-07-22

Similar Documents

Publication Publication Date Title
AU753077B2 (en) Combination of a GABA-A alpha 5 inverse agonist and an acetylcholinesterase inhibitor
BG64972B1 (bg) Средство с антидепресивно действие
HU194053B (en) Process for preparing pharmaceutical compositions containing a combination of dihidro-pyridines and ace-inhibitors
CA2003289C (en) Use of trifluoromethylphenyl-tetrahydropyridines for the preparation of pharmaceutical compositions useful for the treatment of anxiety and anxio-depressive disorders
JP2002537258A5 (fi)
US4859665A (en) Antihypertensive combination products containing a dihydropyridine and a pyridazodiazepine
JPH0334926A (ja) 抗不安薬
HU199684B (en) Process for producing pharmaceutical compositions containing 2-pyrimidinyl-1-piperazin derivatives against alcoholism
LU87034A1 (fr) Association medicamenteuse a base d'un inhibiteur calcique
FR2690847A1 (fr) Compositions à activité agoniste des récepteurs analogues à 5HT1 sélective.
AU752013B2 (en) Combination of a GABA-A alpha 5 inverse agonist and a nicotinic agonist
EP1248651B1 (fr) Produit comprenant un inhibiteur de la transduction des signaux des proteines g heterotrimeriques en association avec un agent anti-hypertenseur pour une utilisation therapeutique dans le traitement de l'hypertension arterielle
CA1327163C (en) Anxiolytically active piperazine derivatives
US6455552B1 (en) Combination of a GABAA α5 inverse agonist and a muscarinic agonist
CA2219455C (fr) Utilisation de derives de pyrrolidine au traitement de l'alcoolisme
US4956361A (en) New combination products having an antidepressant action
NL8002041A (nl) Werkwijze voor het bereiden van een analgetisch en myotonolytisch geneesmiddel.
HU204433B (en) Process for producing pharmaceutical composition against artheriosclerosis containing dl-5- /2-benzyl-3,4-dihydro-2h-benzopiran-6-yl)-methyl/-thiazolidine- -2,4-dion
LU85331A1 (fr) Nouvelle association medicamenteuse pour le traitement de l'hypertension
FR2792199A1 (fr) Utilisation de l'osanetant pour la preparation de medicaments utiles dans le traitement des troubles de l'humeur
EA003055B1 (ru) Способ лечения легочной гипертензии
KR930004646B1 (ko) 심기능 부전의 예방 및 치료제
FR2639227A1 (fr) Utilisation de derives du chromane pour le traitement des etats depressifs
EP1161238A1 (fr) Traitement de la sclerose laterale amyotrophique avec une association de riluzole et d'un antagoniste des recepteurs ampa
HU196125B (en) Process for producing pharmaceutical comprising 3-(aminopropoxy)-indole derivatives combined with diuretic